Katherina Orellana, Head of Business Development Europe, is pleased to introduce a seminar featuring Iolanda Micco, where she explores the potential of small molecules to tackle “undruggable targets”.
Abstract for the talk: The disease relevance and druggability of novel targets rarely align. However, emerging drug mechanisms and modalities are reshaping our perspective on “undruggable targets.” We will explore how to utilize effective lead-finding strategies to tackle challenging targets with small molecules.
This talk was also presented at the Discovery Europe conference, and because of its great success, we are now bringing it to another two cities:
Lund
📍 Location: Medicon Village, Scheelevägen 1 • Inspira building
📅 Date: Wednesday, August 21 – 14:00-15:00
Copenhagen
UPDATED TIME – 13:00-14:00
📍 Location: Symbion Fruebjergvej, Fruebjergvej 3 • Room K3
📅 Date: Thursday, August 22 – 13:00-14:00
About the Speaker:
Dr. Iolanda Micco is the Head of Discovery Chemistry at Axxam in Italy, a leading provider of high-quality services for the identification of small molecules in drug discovery research. With a PhD in medicinal chemistry from the University of Siena, Italy, she boasts more than 15 years of international experience in pivotal management and strategic roles.
Prior to her current role, she directed medicinal chemistry activities at Scandion Oncology in Denmark and served as Associate Director of Chemistry and Alliances at Vipergen. Before her ventures in Denmark, she covered a teaching position in Singapore and led interdisciplinary drug discovery programs at Siena Biotech, in Italy.